🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/12/2011 | 7,30 | 7,39 | 7,19 | 7,36 | +0,34% | 2,73% | 149.239 |
| 06/12/2011 | 7,42 | 7,45 | 7,21 | 7,33 | -0,84% | 3,37% | 161.262 |
| 05/12/2011 | 7,37 | 7,45 | 7,21 | 7,39 | +1,54% | 3,22% | 205.505 |
| 02/12/2011 | 7,42 | 7,44 | 7,02 | 7,28 | -0,93% | 5,55% | 118.622 |
| 01/12/2011 | 7,32 | 7,42 | 7,24 | 7,35 | +0,43% | 2,56% | 203.260 |
| 30/11/2011 | 7,29 | 7,33 | 7,11 | 7,32 | +2,80% | 3,08% | 324.447 |
| 29/11/2011 | 7,21 | 7,23 | 7,07 | 7,12 | -0,44% | 2,17% | 199.894 |
| 28/11/2011 | 7,06 | 7,28 | 6,89 | 7,15 | +4,47% | 5,48% | 411.971 |
| 25/11/2011 | 6,76 | 6,90 | 6,76 | 6,84 | +1,01% | 2,12% | 103.394 |
| 23/11/2011 | 6,69 | 6,89 | 6,69 | 6,77 | +0,93% | 3,07% | 285.815 |
| 22/11/2011 | 6,59 | 6,89 | 6,59 | 6,71 | +1,60% | 4,55% | 181.139 |
| 21/11/2011 | 6,84 | 6,98 | 6,55 | 6,61 | -4,77% | 6,29% | 995.142 |
| 18/11/2011 | 6,90 | 7,05 | 6,85 | 6,94 | +0,72% | 2,89% | 403.635 |
| 17/11/2011 | 6,92 | 7,08 | 6,84 | 6,89 | -0,90% | 3,51% | 147.155 |
| 16/11/2011 | 7,11 | 7,18 | 6,93 | 6,95 | -3,05% | 3,51% | 157.094 |
| 15/11/2011 | 7,28 | 7,47 | 7,14 | 7,17 | +0,00% | 4,54% | 367.408 |
| 14/11/2011 | 7,50 | 7,50 | 7,11 | 7,17 | -5,04% | 5,16% | 289.662 |
| 11/11/2011 | 6,91 | 7,61 | 6,91 | 7,55 | +10,81% | 10,11% | 471.442 |
| 10/11/2011 | 7,68 | 7,69 | 6,80 | 6,81 | -10,49% | 11,62% | 647.772 |
| 09/11/2011 | 7,48 | 7,95 | 7,38 | 7,61 | +1,67% | 7,67% | 598.079 |
| 08/11/2011 | 9,92 | 9,93 | 7,34 | 7,49 | -22,88% | 26,10% | 1.797.284 |
| 07/11/2011 | 9,83 | 9,83 | 9,38 | 9,71 | -0,89% | 4,57% | 115.416 |
| 04/11/2011 | 9,69 | 9,88 | 9,66 | 9,79 | -0,19% | 2,25% | 289.983 |
| 03/11/2011 | 9,78 | 9,84 | 9,43 | 9,81 | +1,75% | 4,15% | 189.956 |
| 02/11/2011 | 9,38 | 9,66 | 9,31 | 9,64 | +4,18% | 3,73% | 196.047 |
| 01/11/2011 | 8,86 | 9,35 | 8,81 | 9,26 | +0,95% | 6,12% | 453.489 |
| 31/10/2011 | 9,33 | 9,59 | 9,15 | 9,17 | -3,16% | 4,75% | 288.540 |
| 28/10/2011 | 9,55 | 9,65 | 9,21 | 9,47 | -0,98% | 4,57% | 583.171 |
| 27/10/2011 | 9,20 | 9,57 | 9,05 | 9,56 | +6,98% | 5,63% | 254.556 |
| 26/10/2011 | 8,78 | 8,99 | 8,57 | 8,94 | +3,39% | 4,76% | 360.194 |